Approval · Notice of Compliance 17522 · 2015
GENVOYA: Notice of Compliance 17522
Issued November 27, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17522
- Date
- November 27, 2015
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GENVOYA | 02449498 | Marketed |
Medicinal ingredients
- EMTRICITABINE 200 MG per TAB
- ELVITEGRAVIR 150 MG per TAB
- COBICISTAT 150 MG per TAB
- TENOFOVIR ALAFENAMIDE FUMARATE 10 MG per TAB